GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,605.50p
   
  • Change Today:
    -4.50p
  • 52 Week High: 1,812.50
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,144.96m
  • Volume: 518,521
  • Market Cap: £66,547m
  • RiskGrade: 129

Latest Deals

Traded Action Notifier PriceAmountValue
11-Jun-24 Transfer From Julie Brown 0.000p 8 £0.00
11-Jun-24 Buy Julie Brown 1,623.24p 8 £129.86
11-Jun-24 Transfer From Emma Walmsley 0.000p 8 £0.00
11-Jun-24 Buy Emma Walmsley 1,623.24p 8 £129.86

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
11-Jun-24 Buy Emma Walmsley 1,623.24p 8 £129.86
11-Jun-24 Buy Julie Brown 1,623.24p 8 £129.86
11-Jun-24 Transfer From Emma Walmsley 0.000p 8 £0.00
11-Jun-24 Transfer From Julie Brown 0.000p 8 £0.00

Director Shareholdings

Notifier Holding Value*
Vishal Sikka 253,466,508 £4,069,404,786
Hal Barron 3,373,198 £54,156,694
Emma Walmsley 2,190,887 £35,174,691
Jonathan Symonds 54,143 £869,266
Julie Brown 42,011 £674,487
Charles Bancroft 25,597 £410,960
Jesse Goodman 11,157 £179,126
Anne Beal 3,375 £54,186
Harry (Hal) C. Dietz 3,118 £50,060
Elizabeth (Liz) McKee Anderson 2,113 £33,924

Major Shareholders

Notifier** Holding Value*
Dodge & Cox 253,464,108 £4,069,366,254
Dodge & Cox 253,464,108 £4,069,366,254
BlackRock Inc 231,975,400 £3,724,365,047
GSK plc 197,068,169 £3,163,929,453
The Capital Group Companies, Inc. 159,068,073 £2,553,837,912
Legal & General Group Plc 95,878,187 £1,539,324,292

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,605.50p
Change Today -4.50p
% Change -0.28 %
52 Week High 1,812.50
52 Week Low 1,316.00
Volume 518,521
Shares Issued 4,144.96m
Market Cap £66,547m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
54.47% below the market average54.47% below the market average54.47% below the market average54.47% below the market average54.47% below the market average
37.25% above the sector average37.25% above the sector average37.25% above the sector average37.25% above the sector average37.25% above the sector average
Price Trend
30.43% above the market average30.43% above the market average30.43% above the market average30.43% above the market average30.43% above the market average
47.17% above the sector average47.17% above the sector average47.17% above the sector average47.17% above the sector average47.17% above the sector average
Income
21.41% above the market average21.41% above the market average21.41% above the market average21.41% above the market average21.41% above the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Growth
20.14% below the market average20.14% below the market average20.14% below the market average20.14% below the market average20.14% below the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

What The Brokers Say

Strong Buy 8
Buy 4
Neutral 10
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q1 Q4
Ex-Div 16-May-24 22-Feb-24
Paid 11-Jul-24 11-Apr-24
Amount 15.00p 16.00p

Trades for 14-Jun-2024

Time Volume / Share Price
12:01 71 @ 1,605.25p
12:01 330 @ 1,605.50p
12:01 645 @ 1,605.50p
12:01 327 @ 1,605.50p
12:01 645 @ 1,605.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page